Home › Trial NCT04981912
Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients
- Trial IDNCT04981912
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorUniversity of California, San Diego
- Enrollment4
- Start date2021-09-02
- ConditionsChronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.